Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A European, Observational, 3-Year Cohort Comparative Study on the Safety of the Fixed Dose Combination Pravastatin 40 mg/Fenofibrate 160 mg vs. Statin Alone in Real Clinical Practice: The POSE Study.
Papadopoulos N, Arvaniti E, Angelopoulos T, Tziomalos K, Tembra MS, Diaz JL, De Niet S, Da Silva S, Doupis J. Papadopoulos N, et al. Among authors: tziomalos k. Pharmacoepidemiol Drug Saf. 2024 Nov;33(11):e70047. doi: 10.1002/pds.70047. Pharmacoepidemiol Drug Saf. 2024. PMID: 39492463
The effect of lipid-lowering treatment on indices of MASLD in familial hypercholesterolemia patients.
Boutari C, Rizos CV, Liamis G, Skoumas I, Rallidis L, Garoufi A, Kolovou G, Sfikas G, Tziomalos K, Skalidis E, Kotsis V, Doumas M, Stamatelopoulos K, Lambadiari V, Anagnostis P, Boufidou A, Giannakopoulou V, Anastasiou G, Petkou E, Vlachopoulos C, Dima I, Fakas G, Papathanasiou KA, Attilakos A, Kolovou V, Koumaras C, Agapakis D, Zacharis E, Antza C, Milionis H, Liberopoulos E, Mantzoros CS. Boutari C, et al. Among authors: tziomalos k. Clin Nutr. 2024 Oct 16;43(12):84-91. doi: 10.1016/j.clnu.2024.10.020. Online ahead of print. Clin Nutr. 2024. PMID: 39437569
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study.
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). Lancet Diabetes Endocrinol. 2024 Nov;12(11):811-823. doi: 10.1016/S2213-8587(24)00221-3. Epub 2024 Oct 4. Lancet Diabetes Endocrinol. 2024. PMID: 39374602 Free article.
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN, Hovingh GK, Hardt-Lindberg S, Frenkel O, Weeke PE, Rasmussen S, Goudev A, Lang CC, Urina-Triana M, Pietilä M, Lincoff AM; SELECT Trial Investigators. Deanfield J, et al. Lancet. 2024 Aug 24;404(10454):773-786. doi: 10.1016/S0140-6736(24)01498-3. Lancet. 2024. PMID: 39181597 Free article. Clinical Trial.
New perspectives in the management of diabetic nephropathy.
Psyllaki A, Tziomalos K. Psyllaki A, et al. Among authors: tziomalos k. World J Diabetes. 2024 Jun 15;15(6):1086-1090. doi: 10.4239/wjd.v15.i6.1086. World J Diabetes. 2024. PMID: 38983809 Free PMC article.
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, Baeres FMM, Idorn T, Bosch-Traberg H, Lausvig NL, Pratley R; FLOW Trial Committees and Investigators. Perkovic V, et al. N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24. N Engl J Med. 2024. PMID: 38785209 Clinical Trial.
Advances in the Pathogenesis of Diabetic Kidney Disease.
Kourtidou C, Tziomalos K. Kourtidou C, et al. Among authors: tziomalos k. Int J Mol Sci. 2024 Apr 22;25(8):4563. doi: 10.3390/ijms25084563. Int J Mol Sci. 2024. PMID: 38674147 Free PMC article.
Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry.
Rallidis LS, Rizos CV, Papathanasiou KA, Liamis G, Skoumas I, Garoufi A, Kolovou G, Tziomalos K, Skalidis E, Kotsis V, Sfikas G, Doumas M, Anagnostis P, Lambadiari V, Giannakopoulou V, Kiouri E, Anastasiou G, Petkou E, Koutagiar I, Attilakos A, Kolovou V, Zacharis E, Antza C, Koumaras C, Boutari C, Liberopoulos E. Rallidis LS, et al. Among authors: tziomalos k. J Cardiovasc Med (Hagerstown). 2024 May 1;25(5):370-378. doi: 10.2459/JCM.0000000000001612. Epub 2024 Mar 19. J Cardiovasc Med (Hagerstown). 2024. PMID: 38526957
Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023.
Katsiki N, Filippatos T, Vlachopoulos C, Panagiotakos D, Milionis H, Tselepis A, Garoufi A, Rallidis L, Richter D, Nomikos T, Kolovou G, Kypreos K, Chrysohoou C, Tziomalos K, Skoumas I, Koutagiar I, Attilakos A, Papagianni M, Boutari C, Kotsis V, Pitsavos C, Elisaf M, Tsioufis K, Liberopoulos E. Katsiki N, et al. Among authors: tziomalos k. Atheroscler Plus. 2024 Feb 17;55:74-92. doi: 10.1016/j.athplu.2024.01.004. eCollection 2024 Mar. Atheroscler Plus. 2024. PMID: 38425675 Free PMC article. Review.
Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry.
Barkas F, Rizos CV, Liamis G, Skoumas I, Garoufi A, Rallidis L, Kolovou G, Tziomalos K, Skalidis E, Sfikas G, Kotsis V, Doumas M, Anagnostis P, Lambadiari V, Anastasiou G, Koutagiar I, Attilakos A, Kiouri E, Kolovou V, Polychronopoulos G, Koutsogianni AD, Zacharis E, Koumaras C, Antza C, Boutari C, Liberopoulos E. Barkas F, et al. Among authors: tziomalos k. J Clin Lipidol. 2024 May-Jun;18(3):e394-e402. doi: 10.1016/j.jacl.2024.01.005. Epub 2024 Jan 24. J Clin Lipidol. 2024. PMID: 38331687
399 results